HealthCare Global Enterprises Limited

NSEI:HCG Voorraadrapport

Marktkapitalisatie: ₹59.9b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

HealthCare Global Enterprises Toekomstige groei

Future criteriumcontroles 4/6

De verwachting is dat HealthCare Global Enterprises de winst en omzet met respectievelijk 39.3% en 13.5% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 41.7% per jaar.

Belangrijke informatie

39.3%

Groei van de winst

41.7%

Groei van de winst per aandeel

Healthcare winstgroei26.2%
Inkomstengroei13.5%
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

Good

Laatst bijgewerkt06 Sep 2024

Recente toekomstige groei-updates

HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next

Feb 11
HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next

Recent updates

We Take A Look At Why HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation Is Well Earned

Sep 19
We Take A Look At Why HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation Is Well Earned

HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next

Feb 11
HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next

We Think Shareholders Will Probably Be Generous With HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation

Sep 14
We Think Shareholders Will Probably Be Generous With HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation

A Look At The Fair Value Of HealthCare Global Enterprises Limited (NSE:HCG)

Sep 05
A Look At The Fair Value Of HealthCare Global Enterprises Limited (NSE:HCG)

HealthCare Global Enterprises Limited's (NSE:HCG) Business Is Yet to Catch Up With Its Share Price

May 17
HealthCare Global Enterprises Limited's (NSE:HCG) Business Is Yet to Catch Up With Its Share Price

Does HealthCare Global Enterprises (NSE:HCG) Have A Healthy Balance Sheet?

Jun 24
Does HealthCare Global Enterprises (NSE:HCG) Have A Healthy Balance Sheet?

Shareholders Shouldn’t Be Too Comfortable With HealthCare Global Enterprises' (NSE:HCG) Strong Earnings

Jun 03
Shareholders Shouldn’t Be Too Comfortable With HealthCare Global Enterprises' (NSE:HCG) Strong Earnings

Is HealthCare Global Enterprises (NSE:HCG) Using Too Much Debt?

Dec 08
Is HealthCare Global Enterprises (NSE:HCG) Using Too Much Debt?

What Does HealthCare Global Enterprises Limited's (NSE:HCG) Share Price Indicate?

Jun 25
What Does HealthCare Global Enterprises Limited's (NSE:HCG) Share Price Indicate?

Insider Buying: The HealthCare Global Enterprises Limited (NSE:HCG) Executive Chairman Just Bought ₹2.4m Worth Of Shares

Mar 14
Insider Buying: The HealthCare Global Enterprises Limited (NSE:HCG) Executive Chairman Just Bought ₹2.4m Worth Of Shares

The HealthCare Global Enterprises (NSE:HCG) Share Price Is Up 51% And Shareholders Are Holding On

Mar 03
The HealthCare Global Enterprises (NSE:HCG) Share Price Is Up 51% And Shareholders Are Holding On

Here's Why HealthCare Global Enterprises (NSE:HCG) Can Afford Some Debt

Jan 27
Here's Why HealthCare Global Enterprises (NSE:HCG) Can Afford Some Debt

How Many HealthCare Global Enterprises Limited (NSE:HCG) Shares Did Insiders Buy, In The Last Year?

Dec 23
How Many HealthCare Global Enterprises Limited (NSE:HCG) Shares Did Insiders Buy, In The Last Year?

Winst- en omzetgroeiprognoses

NSEI:HCG - Toekomstschattingen van analisten en financiële gegevens uit het verleden (INR Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
3/31/202730,6782,311N/AN/A1
3/31/202625,0971,2071,557N/A9
3/31/202522,291745-294N/A8
6/30/202419,770526N/AN/AN/A
3/31/202419,1214829892,846N/A
12/31/202318,592353N/AN/AN/A
9/30/202318,1403719222,197N/A
6/30/202317,471309N/AN/AN/A
3/31/202316,9442931,1842,516N/A
12/31/202216,174270N/AN/AN/A
9/30/202215,507-2641,1562,364N/A
6/30/202214,827694N/AN/AN/A
3/31/202213,9785371,4892,201N/A
12/31/202113,312-544N/AN/AN/A
9/30/202112,472-3791,0891,510N/A
6/30/202111,431-1,633N/AN/AN/A
3/31/202110,134-1,9358511,205N/A
12/31/20209,858-1,349N/AN/AN/A
9/30/20209,897-1,2847511,271N/A
6/30/202010,202-1,284N/AN/AN/A
3/31/202010,956-1,0672231,301N/A
12/31/201910,832-718N/AN/AN/A
9/30/201910,541-552N/AN/AN/A
6/30/201910,210-394N/AN/AN/A
3/31/20199,787-248-903985N/A
12/31/20189,430-135N/AN/AN/A
9/30/20189,004-41N/AN/AN/A
6/30/20188,661124N/AN/AN/A
3/31/20188,307205N/A978N/A
12/31/20177,909257N/AN/AN/A
9/30/20177,608278N/AN/AN/A
6/30/20177,237219N/AN/AN/A
3/31/20177,001230N/A913N/A
12/31/20166,705208N/AN/AN/A
9/30/20166,392133N/AN/AN/A
6/30/20166,08167N/AN/AN/A
3/31/20165,842-178N/A732N/A
12/31/20155,611-33N/AN/AN/A
9/30/20155,4949N/A763N/A
6/30/20155,3239N/AN/AN/A
3/31/20155,1948N/A597N/A
3/31/20144,513-356N/A514N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei HCG ( 39.3% per jaar) ligt boven de spaarquote ( 6.7% ).

Winst versus markt: De winst van HCG ( 39.3% per jaar) zal naar verwachting sneller groeien dan de Indian markt ( 17.3% per jaar).

Hoge groeiwinsten: De winst van HCG zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van HCG ( 13.5% per jaar) zal naar verwachting sneller groeien dan de markt Indian ( 10.1% per jaar).

Hoge groei-inkomsten: De omzet van HCG ( 13.5% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van HCG naar verwachting over 3 jaar hoog zal zijn

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y